ArcticZymes Technologies ASA (DE:B4V) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
ArcticZymes Technologies ASA announced the publication of a research paper in ‘Nucleic Acid Research’ journal, discussing a novel RNA restriction enzyme, ET-N1, which could revolutionize RNA research and therapeutics. The enzyme offers unique molecular cutting functions, enhancing the precision of RNA molecule fragmentation. The breakthrough, supported by an innovation grant, was a collaborative effort involving prestigious academic and research institutions.
For further insights into DE:B4V stock, check out TipRanks’ Stock Analysis page.